A recent study of over 55,000 people with obesity (without diabetes) found that those taking semaglutide , including Ozempic, had a higher risk of being diagnosed with gastroparesis compared to people using other weight-loss treatments
If a mix-up occurs, contact your healthcare provider immediately
Ranji Cui, [email protected] This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
When reconstituting, inject the bacteriostatic water slowly down the side of the vial rather than directly onto the powder
Published August 29, 2024